Fred Hutchinson Cancer Research Center (Fred Hutch), home of three Nobel laureates, is an independent, nonprofit research institution dedicated to the development and advancement of biomedical research to eliminate cancer and other potentially fatal diseases. Recognized internationally for its pioneering work in bone-marrow transplantation, Fred Hutchs five scientific divisions collaborate to form a unique environment for conducting basic and applied science. The Fred Hutch, in collaboration with its clinical and research partners, the University of Washington and Seattle Childrens, is the only National Cancer Institute-designated comprehensive cancer center in the Pacific Northwest.
At Fred Hutch, we believe that the innovation, collaboration, and rigor that result from diversity and inclusion are critical to our mission of eliminating cancer and related diseases. We seek employeeswho bringdifferent and innovativeways of seeing the world and solving problems.Fred Hutch is in pursuit of becoming an antiracist organization.Weare committed to ensuring that all candidates hired share our commitment to diversity,antiracism, and inclusion.
The Jerome Laboratory in the Vaccine and Infectious Disease Division at the Fred Hutchinson Cancer Research Center is recruiting a Staff Scientist to conduct laboratory bench research to evaluate cure strategies and gene therapy for persistent viral infections including herpes simplex, hepatitis B, and HIV.
Responsibilities include independently designing experimental approaches to testing the efficacy of candidate ccurative therapies for persistent viral infections both in vitro and in vivo, and ensuring appropriate experimental performance, and sample acquisition and analysis.
The research will require working with small animal models (mice, guinea pigs). Technical approaches will include gene editing, AAV vectors, droplet digital and quantitative PCR assays, sequence-based assays, and other clinical and research assays as required.
The scientist is expected to help write manuscripts and grant proposals, and to present research at scientific meetings.
Ph.D. in the field of Virology, Gene Therapy, Microbiology or experience in a related area.
At least four years in related area or equivalent combination of education/experience.
Experience in gene therapy is desirable, as is an understanding of basic viral biology.
Experience using small animal models will be advantageous.
Experience in evaluation of viral sequence diversity. The candidate should be enthusiastic about this research area, goal-oriented, a self-starter, and be able to work independently in a team environment.
Strong analytical, writing, communication (in English), and problem-solving skills are desired.
A statement describing your commitment and contributions toward greater diversity, equity, inclusion, and antiracism in your career or that will be made through your work at Fred Hutch is requested of all finalists.
Our Commitment to Diversity
We are proud to be an Equal Employment Opportunity (EEO) and Vietnam Era Veterans Readjustment Assistance Act (VEVRAA) Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability (physical or mental), marital or veteran status, genetic information, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. If due to a disability you need assistance/and or a reasonable accommodation during the application or recruiting process, please send a request to our Employee Services Center at email@example.com or by calling 206-667-4700.
At Fred Hutchinson Cancer Research Center, teams of world-renowned scientists and humanitarians work together to prevent, diagnose and treat cancer, HIV/AIDS and other diseases. Researchers are discovering new ways to detect cancers earlier, improve treatments, and learn how to prevent cancers from growing. Although Fred Hutchinson opened its doors in 1975, its history began about 20 years before that. In 1962 Fred Hutchinson envisioned a center devoted to studying cancer, a disease that took his brother’s life. Today Fred Hutchinson is contributing to the next waves of breakthrough treatments and prevention strategies. Fred Hutchinson collaborates with the Seattle Cancer Alliance, the National Cancer Institute, and the University of Washington.